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HISTORY
 78 year old black female with history of invasive ductal
carcinoma in left breast status post lumpectomy and
cytotoxic chemotherapy
 Patient developed acute onset bullae on left breast during
24th cycle of radiation therapy (RT) and which was
diagnosed as radiation dermatitis by her radiation
oncologist
 Patient continued to develop new tense bullae on the left
breast after cessation of RT
 Within 4 weeks, patient was hospitalized with dysphagia,
odynophagia and oropharyngeal ulcerations
 At 8 weeks, patient developed new tense bullae on
extremities and presented to dermatology

CLINICAL PHOTOS





High potency topical corticosteroids
Oral prednisone taper with improvement
Doxycycline 100 mg BID with niacinamide 500 mg BID
Patient continued to improve with new vesicles and
bullae responsive to topical corticosteroids
 Proposed next step is dapsone to avoid
immunosuppression

Figure 1.
Multiple tense
serosanguinous
filled bullae and
erosions
involving the left
breast.

DISCUSSION
 Radiation dermatitis is not always the answer
o Persistent development of bullae after cessation of RT
and spread of bullae to areas outside the area of RT
indicate need for further work up

 Radiation induced bullous pemphigoid

EXAMINATION

o Rare complication of RT
o Most commonly seen in patients with breast cancer but
has been associated with lung, vulvar and esophageal
carcinomas
o Cases commonly occur at the time of RT or up to 6
months after cessation of RT
o Majority of cases remain localized to RT-treated areas,
and rarely is there involvement of oral mucosa
o Appears more indolent than non-RT BP and may respond
to topical and oral corticosteroids

 Entirety of left breast exhibited multiple tense
serosanguinous filled bullae and erosions (Figure 1)
 Bullae were interspersed by well-demarcated depigmented
patches with perifollicular macules of repigmentation
 Three tense serosanguinous bullae were present on the
right lower extremity and left ankle
 Two linear erythematous erosions with mild fibrinous debris
extended from the hard palate down the oropharynx
(Figure 2)
 Nikolsky sign was negative

PATHOLOGY
 H&E of punch biopsy from right medial thigh
o Separation at the dermal epidermal junction, resulting in
subepidermal blister with sparse infiltrate of lymphocytes
and eosinophils in the underlying dermis

 Direct immunofluorescence
o IgG and C3 with 3+ linear staining at the basement
membrane zone

 Salt split skin analysis
o Localization of IgG and C3 in a linear pattern to the
epidermal side of dermal-epidermal junction

TREATMENT

Figure 2.
Linear erythematous
erosions with mild
fibrinous debris
extending from the
hard palate down the
oropharynx.

 Proposed etiologies
o Breast cancer cells express a mixture of
hemidesmosomes, similar to those found in the
basement membrane
o Release of cell contents following RT could serve as an
antigen for immune cells and lead to production of BP
autoantibodies
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